Anna J. Gilman

TL;DR: A high-throughput microfluidic mixing device, the herringbone-chip, or “HB-Chip,” is described, which provides an enhanced platform for CTC isolation and reveals microclusters of CTCs, previously unappreciated tumor cell aggregates that may contribute to the hematogenous dissemination of cancer.

TL;DR: A microfluidic device is adapted for efficient capture of CTCs from an endogenous mouse pancreatic cancer model and single-molecule RNA sequencing is subjected, identifying Wnt2 as a candidate gene enriched in C TCs, to identify candidate therapeutic targets to prevent the distal spread of cancer.

TL;DR: This corrects the article to show that the method used to derive the H2O2 “spatially aggregating force” is based on a two-step process, not a single step, like in the case of H1N1.

TL;DR: USGRA can be implemented safely and effectively for PRFA of OO as an alternative primary anesthetic technique and decreases post-procedural discomfort without ambulation difficulty, prolonged neurosensory deficit, or recovery time.